Showing results (61-70 of 162) with videos related to

Sort By:
Pageof 17
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Diagnostic significance and antigen specificity of antineutrophil cytoplasmic antibodies in renal diseases. A prospective multicentre study. Italian Group of Renal ImmunopathologyR A Sinico, A Radice, C Pozzi, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|February 17, 2005
A reconsideration of the domestication geography of tetraploid wheatsH Ozkan, A Brandolini, C Pozzi, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 10, 2007
[Corticosteroid treatment for a first episode of steroid-sensitive nephrotic syndrome (SSNS) in children: guideline from the Italian Society of Nephrology]A Lupo, C Pozzi, P Passerini, et al.
Clinical Nephrology|May 1, 1983
Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathyA De Vecchi, G Montagnino, C Pozzi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1991
Utility of immunofluorescence of urine sediment for identifying patients with renal disease due to monoclonal gammopathiesG B Fogazzi, C Pozzi, P Passerini, et al.
International Journal of Clinical & Laboratory Research|May 22, 1998
Different pattern of cytokine production and mRNA expression by lymphoid and non-lymphoid cells isolated from human palatine tonsilG Lisignoli, C Pozzi, S Toneguzzi, et al.
Virchows Archiv : an International Journal of Pathology|January 1, 1994
Light chain deposition disease of the kidney. Morphological aspects in 24 patientsE H Strøm, G B Fogazzi, G Banfi, et al.
Applied and Environmental Microbiology|September 16, 2018
G Schwob, M Roy, A C Pozzi, et al.
Clinical Nephrology|May 1, 1995
Renal disease and patient survival in light chain deposition diseaseC Pozzi, G B Fogazzi, G Banfi, et al.
European Neurology|January 1, 1995
Proglumide, a cholecystokinin receptor antagonist, reduces neuroleptic action in Huntington's choreaR Piolti, I Appollonio, M Perego, et al.
Pageof 17